“NUCLEAR RECEPTOR BINDING SET DOMAIN PROTEINS: ORCHESTRATING ANTI-TUMOR IMMUNITY AND THE PROMISE OF TARGETED DEGRADATION THERAPIES”, Eur. J. Emerg. Mol. Sci., vol. 1, no. 01, pp. 69–79, Dec. 2024, Accessed: Jan. 15, 2026. [Online]. Available: https://parthenonfrontiers.com/index.php/ejems/article/view/31